Key result
A dedicated inpatient transitions of care pharmacist reduced 30-day re-presentation rates compared to historical controls (OR 0.43; 95% CI 0.30-0.61; NNT 9).
Why the study?
Does a dedicated inpatient transitions of care pharmacist reduce hospital re-presentations in adult patients discharging home?
Population
1,605 adult patients discharging home from study units in a community hospital.
Comparison
Dedicated inpatient transitions of care… vs Historical control.
Design
Cohort
Follow-up
365 days
Authors
Loading...
May support pharmacist-led transitions programs; leaves open causal benefit pending randomized confirmation.
Cohort (n=1,605)
Does a dedicated inpatient transitions of care pharmacist reduce hospital re-presentations in adult patients discharging home?
Odds Ratio: 0.43 (95% CI 0.3–0.61)
Absolute Risk Reduction: 11%
Number Needed to Treat: 9
Integrating a dedicated pharmacist into transitions of care significantly reduces hospital re-presentations up to 1 year post-discharge and yields substantial institutional cost savings.
Rafferty et al. (2016) conducted a cohort in Transitions of care (n=1,605). Dedicated inpatient transitions of care (TOC) pharmacist vs. Historical control was evaluated on 30 day re-presentation rate (OR 0.43, 95% CI 0.30-0.61). A dedicated inpatient transitions of care pharmacist reduced 30-day re-presentation rates compared to historical controls (OR 0.43; 95% CI 0.30-0.61; NNT 9).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: